Medical Affairs Transformation in Specialty Pharma: Next-Level Collaboration at the Core

Area of Science:

• Pharmaceutical industry
• Medical Affairs
• Healthcare innovation

Background:

• Rising societal expectations for timely, evidence-based medicine.
• The need for collaborative efficiencies and shared learning in pharmaceutical development.
• The imperative for pharmaceutical companies to adapt to evolving healthcare landscapes.

Purpose of the Study:

• To describe the initial phase of a medical transformation process in a global pharmaceutical company.
• To examine and reshape the structure, culture, and tools of a Medical Affairs organization.
• To foster innovation through collective intelligence and patient-centric outcomes.

Main Methods:

• Initiated a broad review leveraging collective intelligence.
• Focused on meaningful patient outcomes.
• Examined and reshaped organizational structure, culture, and tools.

Main Results:

• Diagnostic phase findings reported.
• Initial solutions for transformation implemented.
• Foundation laid for a dynamic, evolving medical organization.

Conclusions:

• Empowered Medical Affairs functions are crucial for meeting patient and societal needs.
• Collaborative efficiencies and shared learning drive innovation in medicine.
• Continuous transformation is essential for pharmaceutical companies to advance evidence-based practice.